Agilent Technologies (NYSE:A) Issues Q1 Earnings Guidance

Agilent Technologies (NYSE:A) updated its first quarter earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.25-1.28 for the period, compared to the consensus estimate of $1.38. The company issued revenue guidance of $1.65-1.68 billion, compared to the consensus revenue estimate of $1.70 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $138.11 on Thursday. The stock has a market capitalization of $39.68 billion, a price-to-earnings ratio of 28.65, a price-to-earnings-growth ratio of 5.91 and a beta of 1.07. The business’s fifty day moving average price is $137.72 and its two-hundred day moving average price is $137.43. Agilent Technologies has a fifty-two week low of $124.10 and a fifty-two week high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 20.54%.

Wall Street Analyst Weigh In

Several analysts have weighed in on A shares. JPMorgan Chase & Co. decreased their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday. Barclays decreased their price target on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research report on Wednesday. Wells Fargo & Company assumed coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. StockNews.com cut Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Sanford C. Bernstein cut their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Hold” and an average target price of $143.40.

Insider Activity at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.